Schoppmeier, Christoph Matthias ORCID: 0000-0002-3269-8920, Deeg, Isabel ORCID: 0000-0003-0306-5873, Wicht, Michael Jochen ORCID: 0000-0003-4693-7184 and Barbe, Anna Greta ORCID: 0000-0003-0169-2582 (2024). Anticholinergic Burden and Dry Mouth Problems Among Older Adults (≥ 50 Years) Receiving Dental Care—A Retrospective, Cross‐Sectional Analysis. Clinical and Experimental Dental Research, 10 (6). pp. 1-9. Wiley. ISSN 2057-4347

[thumbnail of Clinical Exp Dental Res - 2024 - Schoppmeier - Anticholinergic Burden and Dry Mouth Problems Among Older Adults 50.pdf] PDF
Clinical Exp Dental Res - 2024 - Schoppmeier - Anticholinergic Burden and Dry Mouth Problems Among Older Adults 50.pdf
Bereitstellung unter der CC-Lizenz: Creative Commons Attribution.

Download (340kB)
Identification Number:10.1002/cre2.70009

Abstract

[Artikel-Nr.: e70009] Objectives: Anticholinergics cause dry mouth and are highly relevant for dentists, but little is known about the relationships between intake and the occurrence of subjective and objective dry mouth with age. The German anticholinergic burden score (GACB) is a novel anticholinergic score that re‐evaluates medications, particularly, those with classification discrepancies. Material and Methods: We retrospectively investigated the GACB in older patients receiving dental care, evaluated whether GACB is related to xerostomia and unstimulated salivary secretion, and determined the influence of increasing age (beginning at 50 years of age). The GACB score quantified cumulative anticholinergic effects: 0 for no effect, 1 for possible, 2 for moderate, and 3 for strong. Cross‐sectional data in patients ≥ 50 years were collected, including xerostomia with the visual analog scale, unstimulated salivary flow rates, and the GACB scores. Results: Among 172 patients (mean age 65.67 ± 9.51 years), 23.8% had a GACB score ≥ 1. A moderate negative correlation was observed between GACB and unstimulated salivary flow rates (r̅ = −0.51). Patients with GACB ≥ 1 had fewer teeth (mean 21.76 ± 5.41) than those with GACB = 0 (24.07 ± 5.57). Moreover, unstimulated hyposalivation was observed in 61.0% with GACB ≥ 1 versus 6.8% with GACB = 0 (p < 0.001). Escalating chronic systemic conditions and prescribed medications were recorded with increasing age; those aged 76–80 years had the highest burden. Conclusions: The GACB quickly and reliably assesses anticholinergic exposure and risks for oral health in older patients. Routine use in those aged ≥ 50 years could enable early identification of risks and initiation of preventive dental measures. Trial Registration: German Registry for Clinical Trials: DRKS00032877 (https://www.germanctr.de; date of registration: 17.10.2023).

Item Type: Article
Creators:
Creators
Email
ORCID
ORCID Put Code
Schoppmeier, Christoph Matthias
UNSPECIFIED
UNSPECIFIED
Deeg, Isabel
UNSPECIFIED
UNSPECIFIED
Wicht, Michael Jochen
UNSPECIFIED
UNSPECIFIED
Barbe, Anna Greta
UNSPECIFIED
UNSPECIFIED
URN: urn:nbn:de:hbz:38-816545
Identification Number: 10.1002/cre2.70009
Journal or Publication Title: Clinical and Experimental Dental Research
Volume: 10
Number: 6
Page Range: pp. 1-9
Number of Pages: 9
Date: 5 December 2024
Publisher: Wiley
ISSN: 2057-4347
Language: English
Faculty: Faculty of Medicine
Divisions: Faculty of Medicine > Zahn-, Mund- und Kieferheilkunde > Poliklinik für Zahnerhaltung und Parodontologie
Subjects: Medical sciences Medicine
Uncontrolled Keywords:
Keywords
Language
elderly ; German anticholinergic burden score ; hyposalivation ; xerostomia
English
['eprint_fieldname_oa_funders' not defined]: Publikationsfonds UzK
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/81654

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item